Does Trulicity cause hair loss?
By
Dr Drielli Vital-Fujii (PhD)
Author bio
Dr Drielli Vital-Fujii, PhD, is a Pharmacist with expertise in Drug Design and Development, Enzymes, Molecular Modelling, and Photodynamic Therapy. She writes and reviews content on these topics.
Dr Drielli Vital-Fujii’s Highlights:
- Postdoctoral fellow at the Department of Biochemistry at the University of São Paulo, emphasizing therapy of neglected diseases using light.
- PhD in Pharmaceutical Sciences focusing on drug design and development at the Faculty of Pharmaceutical Sciences of the University of São Paulo.
- Six months as an international researcher at the Center for Discovery and Innovation in Parasitic Diseases (University of California San Diego)
- Master’s degree in Pharmaceutical Sciences focusing on drug design and development at the Faculty of Pharmaceutical Sciences of the University of São Paulo.
- Bachelor of Pharmacy at the University of Mogi das Cruzes – São Paulo / Brazil
Professional Experience:
2012 – 2018 Project manager at University of São Paulo – Pharmacy Department
Dr Drielli Vital-Fujii has worked with computational studies, synthesis, biological evaluation, design, and development of new inhibitor candidates for Chagas Disease and Leishmaniasis.
2017 – 2017 International research fellow at University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences – Center for Discovery and Innovation in Parasitic Diseases.
She used Virtual Screening (VS) and High-Throughput Screening (HTS) Integration in the Discovery of new drugs against neglected tropical diseases (NTDs).
2018 – 2019 Faculdades Oswaldo Cruz
Dr Drielli Vital-Fujii was a professor in the Faculty of Pharmacy, teaching the subjects of Pharmaceutical Chemistry and Drug Development.
2019 – 2021 Researcher in Biochemistry University of São Paulo – Biochemistry Department
She applied Photodynamic Therapy in Leishmaniasis Treatment, mentored undergraduate students in scientific activities, and wrote, executed, translated, and reported scientific projects with funding agencies.
2023-2023 UniPiaget – University Center.
Dr Drielli Vital-Fujii was a Biology, Nutrition, Physiotherapy, and Pharmacy professor.
Education:
2018 -2021 Postdoctoral at the Department of Biochemistry at the University of São Paulo
2013 -2018 PhD of Science: Drugs and Medicines at Department of Pharmacy at University of São Paulo
2012 -2013 M.Sc. of Sciences: Drugs and Medicines at the Department of Pharmacy at the University of São Paulo
2005-2008 Bachelor of Pharmacy at the University of Mogi das Cruzes
The leading publications of Dr Drielli Vital-Fujii are:
Vital-Fujii, D.G, Baptista, M.S. (2021). Progress in the photodynamic therapy treatment of Leishmaniasis. Brazilian Journal of Medical and Biological Research, 54, 1-11.
Gatti, F. M., Gomes, R.A., da Fonseca, A.L., Lima, E.J.C., Vital-Fujii, D.G., Taranto, A.G., Varotti, F.P., Trossini, G.H.G. (2020). Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches. Future medicinal chemistry, 13, 233-250.
Silva, E.J., Bezerra-Souza, A., Passero, L.F., Laurenti, M.D., Ferreira, G.M., Fujii, D.G.V., et al. (2018). Synthesis, leishmanicidal activity, structural descriptors and structure-activity relationship of quinoline derivatives. Future medicinal chemistry, 10, 2069-2085.
Leite, F.H.A., Froes, T.Q., da Silva, S.G., de Souza, E.I.M., Vital-Fuji,i D.G., Trossini, G.H.G., et al. (2017). An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. European Journal of Medicinal Chemistry, 132, 322-332.
Vital, D.G., Damasceno, F.S., Rapado, L.N., Silber, A.M., Vilella, F.S., Ferreira, R.S., et al. (2017). Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study. Journal of Biomolecular Structure and Dynamics, 35, 1244–1259.
Mello, J. F.R., Gomes, R.A., Vital-Fujii, D.G., Ferreira, G.M., Trossini, G.H.G. (2017). Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology & Drug Design, 90, 1067-1078.
Pantaleao, S.Q., Fujii, D.G.V., Maltarollo, V.G., da C. Silva, D., Trossini, G.H.G., Weber, K.C., et al. (2017). The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery. Medicinal Chemistry, 13, 706-720.
Vital, D., Arribas, M., Trossini, G. (2014). Molecular Modeling and Docking Application to Evaluate Cruzain Inhibitory Activity by Chalcones and Hydrazides. Letters in Drug Design and Discovery, 11, 249-255.
Blau, L., Menegon, R.F., Trossini, G.H.G., Molino, J.V.D., Vital, D.G., Cicarelli, R.M.B., et al. (2013). Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates. European Journal of Medicinal Chemistry, 67, 142-151.
You can view some of Dr Drielli’s work below and links to her professional profile.
Orcid: https://orcid.org/0000-0001-9270-0466
Research Gate: https://www.researchgate.net/profile/Drielli-Gomes-Vital-Fujii
Scopus: https://www.scopus.com/authid/detail.uri?authorId=55829534000
Google Scholar: https://scholar.google.com/citations?user=F9U50AEAAAAJ&hl=pt-BR
Linkedin: linkedin.com/in/driellivital
Escavador: https://www.escavador.com/sobre/6101380/drielli-gomes-vital
CDIPD: https://cdipd.org/index.php/about-us/visiting-scientists
Does Trulicity cause hair loss?
No, Trulicity is not associated with hair loss as a side effect. It was not reported in any of the clinical trials or research studies.
However, you may experience hair loss if Trulicity fails to manage your diabetes effectively as constant high blood glucose levels can make your blood carry less oxygen and nutrients. (1,2)
If you’re experiencing hair loss on Trulicity, talk to your healthcare provider. It is important to monitor your blood glucose levels frequently to make sure that your medication is working as well as it should.
Factors that can contribute to hair loss while taking Trulicity
Some factors that can contribute to hair loss while taking Trulicity include: (3)
Underlying health conditions: Hair loss can be influenced by certain medical conditions such as thyroid disorders, hormonal imbalances, or autoimmune diseases. These conditions may coincide with the use of Trulicity and contribute to hair loss.
Nutritional deficiencies: Inadequate intake of essential nutrients, such as vitamins and minerals, can affect hair health. Poor nutrition or deficiencies in nutrients like iron, zinc, or biotin may contribute to hair loss. (4)
Stress and emotional factors: Physical or emotional stress can disrupt the normal hair growth cycle and lead to hair loss. The stress associated with managing a medical condition or making lifestyle changes while taking Trulicity may impact hair health.
Genetic predisposition: Some individuals may have a genetic predisposition to hair loss, which can be independent of medication use. If you have a family history of hair loss, it could contribute to your experience while taking Trulicity.
Other medications or treatments: Hair loss can be a side effect of medications other than Trulicity. If you’re taking multiple medications, it’s possible that one of them, or their combination, may contribute to hair loss – like beta-blockers including Propranolol, Carvedilol, Bisoprolol, etc.
What to do if you’re experiencing hair loss while taking Trulicity?
If you notice hair loss while taking Trulicity, reach out to your healthcare provider or doctor to discuss your concerns. They will determine the exact cause of your hair loss and will act accordingly.
Your healthcare provider will assess whether Trulicity could be the potential cause of your hair loss. They may suggest alternative treatments or adjustments to your medication regimen. It is also important to take good care of your overall health.
Maintaining a balanced diet, managing stress levels effectively, and addressing any underlying health conditions or deficiencies can help improve your overall health, including your hair health.
Was this helpful?
References
1.-
Scott LJ. Dulaglutide: A Review in Type 2 Diabetes. Drugs. 2020 Feb;80(2):197-208. doi: 10.1007/s40265-020-01260-9. PMID: 32002850. https://pubmed.ncbi.nlm.nih.gov/32002850/
2.-
Smith LL, Mosley JF 2nd, Parke C, Brown J, Barris LS, Phan LD. Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist. P T. 2016 Jun;41(6):357-60. PMID: 27313432; PMCID: PMC4894510. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894510/
3.-
Phillips TG, Slomiany WP, Allison R. Hair Loss: Common Causes and Treatment. Am Fam Physician. 2017 Sep 15;96(6):371-378. PMID: 28925637. https://pubmed.ncbi.nlm.nih.gov/28925637/
4.-
Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002 Jul;27(5):396-404. doi: 10.1046/j.1365-2230.2002.01076.x. PMID: 12190640. https://pubmed.ncbi.nlm.nih.gov/12190640/
